149 related articles for article (PubMed ID: 10594933)
1. Effects of mistletoe lectin I and ionizing radiation on the glucose and thymidine uptake in tumour cells in vitro.
Kubasova T; Petcu I; Pfüller U; Köteles GJ
Phytother Res; 1999 Dec; 13(8):655-9. PubMed ID: 10594933
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
[TBL] [Abstract][Full Text] [Related]
3. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
Büssing A; Suzart K; Schweizer K
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S9-14. PubMed ID: 9179360
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
[TBL] [Abstract][Full Text] [Related]
6. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
Kunze E; Schulz H; Gabius HJ
J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
[TBL] [Abstract][Full Text] [Related]
7. Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation.
Hostanska K; Vuong V; Rocha S; Soengas MS; Glanzmann C; Saller R; Bodis S; Pruschy M
Br J Cancer; 2003 Jun; 88(11):1785-92. PubMed ID: 12771996
[TBL] [Abstract][Full Text] [Related]
8. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of immunoactive mistletoe lectin-I.
Beuth J
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum.
Lee HS; Kim YS; Kim SB; Choi BE; Woo BH; Lee KC
Cell Mol Life Sci; 1999 Apr; 55(4):679-82. PubMed ID: 10357236
[TBL] [Abstract][Full Text] [Related]
11. Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells.
Kim MS; So HS; Lee KM; Park JS; Lee JH; Moon SK; Ryu DG; Chung SY; Jung BH; Kim YK; Moon G; Park R
Gen Pharmacol; 2000 May; 34(5):349-55. PubMed ID: 11368891
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
13. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
14. Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin.
Lyu SY; Kwon YJ; Joo HJ; Park WB
Arch Pharm Res; 2004 Jan; 27(1):118-26. PubMed ID: 14969350
[TBL] [Abstract][Full Text] [Related]
15. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
[TBL] [Abstract][Full Text] [Related]
16. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
Hajto T; Hostanska K; Weber K; Zinke H; Fischer J; Mengs U; Lentzen H; Saller R
Nat Immun; 1998; 16(1):34-46. PubMed ID: 9789123
[TBL] [Abstract][Full Text] [Related]
17. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.
Hostanska K; Hajto T; Fischer J; Mengs U; Weber K; Lentzen H; Saller R
Cancer Detect Prev; 1999; 23(6):511-23. PubMed ID: 10571662
[TBL] [Abstract][Full Text] [Related]
18. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
Stettin A; Schultze JL; Stechemesser E; Berg PA
Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
[TBL] [Abstract][Full Text] [Related]
19. Mistletoe lectins and their A and B chains.
Franz H
Oncology; 1986; 43 Suppl 1():23-34. PubMed ID: 3543782
[TBL] [Abstract][Full Text] [Related]
20. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
Stein GM; Stettin A; Schultze J; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
